Company Information

RANBAXY LABORATORIES LTD.- (AMALGAMATION)

NSE : NABSE : 500359ISIN CODE : INE015A01028Industry : Pharmaceuticals & DrugsHouse : MNC
BSE859.900 (0 %)
PREV CLOSE ( ) 859.90
OPEN PRICE ( ) 814.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 859.90 (10542)
VOLUME 308222
TODAY'S LOW / HIGH ( )810.30 869.00
52 WK LOW / HIGH ( ) 810.3869
NSE
This Company is not listed in NSE
ChairmanTsutomu Une
Managing DirectorArun Sawhney
Company SecretarySushil K Patawari
Non Executive & Independent DirectorAkihiro Watanabe
Anthony H Wild
Percy K Shroff
Rajesh V Shah
Takashi Shoda
Non Independent & Non Executive DirectorKazunori Hirokawa
Incorporation Year : 16-06 1961

Registered Office :

Address : A-41, Industrial Area Phase V I I I - A,Sahibzada Ajit Singh Nagar, Mohali,
Punjab-160071 .

Phone : 91-172 6678666

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.